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 Editor 
 
I enjoyed reading the work of Ostri et al on long term follow up of patients with diabetic vitrectomy 
(Ostri et al. 2013). The findings on cataract surgery are interesting and I think some of my own data 
can add to the discussion regarding the requirement of cataract surgery. In particular the effect of 
age and gas tamponade use on the development of cataract in this group of patients.  I keep a 
prospective surgical database of all of my cases and from 1999 to 2008 I performed diabetic 
vitrectomy on 222 eyes. Thirty of these were pseudophakic  pre-operatively, 26 had combined 
phakovitrectomy and 2 were aphakic leaving  164 phakic diabetic vitrectomies performed mostly 
with 20g vitrectomy surgery at that time . The mean age was 52 years and 55% were male.  
In these eyes SF6 gas was used in 38(23%), Silicone oil in 6(4%) and long acting gas in 4(3%). All cases 
where oil or long acting gas were used had cataract surgery within 6 months so were excluded them 
from further analysis. 
Two year follow up was available on 132 of these phakic eyes (80%) and 5 year follow up on 90 
(55%). 
Overall 35% had had cataract surgery by 2 years and 54% by 5 years, similar to the findings of Ostri 
et al. However if the patients are divided by age and gas use the findings are interesting. Table 1 
shows the number of patients who underwent cataract surgery divided by age bands and SF6 gas 
use.  
Table 1: Cataract surgery requirement by age band and SF6 gas use.  
  Total number of 
phakic eyes at 
time of 
vitrectomy 
surgery  with 
follow up 
Number of 
eyes where 
SF6 gas was 
used (%) 
Total number of 
eyes who had 
had cataract 
surgery (%) 
Total number of eyes 
with gas who had 
had cataract surgery 
(%) 
2 year 
follow up 
n=132 
Under 
50 years 
old  
67 16(24%) 12(18%) 5(31%) 
 50 -60 
years old  
22 4(18%) 8(36%) 3(75%) 
 Over 60 
years old  
43 10(23%) 26(60%) 9(90%) 
5 year 
Follow up 
N=90 
Under 
50 years 
old  
49 11(22%) 18(37%) 7(63%) 
 50 -60 
years old  
15 3(20%) 8(53%) 3(100%) 
 Over 60 
years old  
26 6(23%) 23(88%) 6(100%) 
 
The actual figures in any one unit will depend on the presence of any degree of cataract pre 
operatively and the threshold for cataract surgery as discussed in the paper by Ostri et al. but it can 
be seen that increasing age substantially increases the risk of cataract surgery being required  as 
does short acting gas use. In patients over 60 years most will require cataract surgery within 5 years 
of surgery and within 2 years if SF6 is required. This is of particular interest with the rising use of 
combined phacovitrectomy in diabetic vitrectomy (Silva et al. 2014).  
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